Stay updated with breaking news from Nasdaq Pcsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Maxim Group reissued their hold rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a research note issued to investors on Friday, Benzinga reports. Processa Pharmaceuticals Stock Performance Shares of PCSA stock opened at $0.42 on Friday. The stock has a market cap of $10.46 million, a price-to-earnings ratio of -0.37 and a […]
Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report)‘s stock had its “hold” rating reissued by investment analysts at Maxim Group in a note issued to investors on Friday, Benzinga reports. Processa Pharmaceuticals Trading Up 1.0 % Shares of NASDAQ PCSA traded up $0.00 during midday trading on Friday, reaching $0.42. 476,549 shares of the company were […]
Hanover, MD., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announced today with great sadness that Virgil Thompson,...
Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report) and BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Processa […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]